Abstract
Urticaria is a common skin disease, which, in its chronic form, is a very disturbing condition. Because histamine is the best-documented chemical mediator of urticaria, histamine1-antagonists are the mainstay of therapy. First-generation anti-histamines are limited by their tendency to produce sedation and anticholinergic side effects. Most of the newer second-generation antihistamines compare well with the earlier agents in efficacy but are not limited by the same adverse side effects. Loratadine may be distinguished from other second-generation antihistamines by its pharmacodynamics profile, as well as its tolerability and safety.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
